<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hoeritzauer I</submitter><funding>ABN/Patrick Berthoud Charitable Trust Clinical Research Training Fellowship</funding><funding>Royal College of Surgeons of Edinburgh</funding><funding>NRS Career Fellowship from NHS Scotland</funding><pagination>2916-2926</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6244667</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>265(12)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The majority of patients presenting with suspected clinical cauda equina syndrome (CES) have no identifiable structural cause for their symptoms ('scan-negative' CES). Understanding these patients aids clinical differentiation and management in CES.&lt;h4>Methods&lt;/h4>A retrospective electronic note review was undertaken of patients presenting with suspected CES, defined as ≥ 1 of acute bladder, bowel, sexual dysfunction or saddle numbness, to a regional neurosciences centre. We investigated radiology, clinical features, psychiatric and functional disorder comorbidities and outcome of patients with 'scan-negative' CES and patients with MRI confirmed compression of the cauda equina ('scan-positive' CES).&lt;h4>Results&lt;/h4>276 patients were seen over 16 months. There were three main radiologically defined patient groups: (1) 'scan-positive' CES (n = 78, mean age 48 years, 56% female), (2) 'scan-negative' CES without central canal stenosis but with lumbosacral nerve root compression not explaining the clinical presentation (n = 87, mean age 43 years, 68% female) and (3) 'scan-negative' CES without neural compromise (n = 104, mean age 42 years, 70% female). In the two 'scan-negative' groups (no neural compromise and nerve root compression), there were higher rates of functional disorders (37% and 29% vs. 9%), functional neurological disorders (12% and 11% vs 0%) and psychiatric comorbidity (53% and 40% vs 20%). On follow-up (mean 13-16 months), only 1 of the 191 patients with 'scan-negative' CES was diagnosed with an explanatory neurological disorder (transverse myelitis).&lt;h4>Conclusions&lt;/h4>The data support a model in which scan-negative cauda equina syndrome arises as an end pathway of acute pain, sometimes with partly structural findings and vulnerability to functional disorders.</pubmed_abstract><journal>Journal of neurology</journal><pubmed_title>The clinical features and outcome of scan-negative and scan-positive cases in suspected cauda equina syndrome: a retrospective study of 276 patients.</pubmed_title><pmcid>PMC6244667</pmcid><funding_grant_id>bursary</funding_grant_id><pubmed_authors>Hoeritzauer I</pubmed_authors><pubmed_authors>Carson A</pubmed_authors><pubmed_authors>Pronin S</pubmed_authors><pubmed_authors>Stone J</pubmed_authors><pubmed_authors>Demetriades AK</pubmed_authors><pubmed_authors>Statham P</pubmed_authors></additional><is_claimable>false</is_claimable><name>The clinical features and outcome of scan-negative and scan-positive cases in suspected cauda equina syndrome: a retrospective study of 276 patients.</name><description>&lt;h4>Background&lt;/h4>The majority of patients presenting with suspected clinical cauda equina syndrome (CES) have no identifiable structural cause for their symptoms ('scan-negative' CES). Understanding these patients aids clinical differentiation and management in CES.&lt;h4>Methods&lt;/h4>A retrospective electronic note review was undertaken of patients presenting with suspected CES, defined as ≥ 1 of acute bladder, bowel, sexual dysfunction or saddle numbness, to a regional neurosciences centre. We investigated radiology, clinical features, psychiatric and functional disorder comorbidities and outcome of patients with 'scan-negative' CES and patients with MRI confirmed compression of the cauda equina ('scan-positive' CES).&lt;h4>Results&lt;/h4>276 patients were seen over 16 months. There were three main radiologically defined patient groups: (1) 'scan-positive' CES (n = 78, mean age 48 years, 56% female), (2) 'scan-negative' CES without central canal stenosis but with lumbosacral nerve root compression not explaining the clinical presentation (n = 87, mean age 43 years, 68% female) and (3) 'scan-negative' CES without neural compromise (n = 104, mean age 42 years, 70% female). In the two 'scan-negative' groups (no neural compromise and nerve root compression), there were higher rates of functional disorders (37% and 29% vs. 9%), functional neurological disorders (12% and 11% vs 0%) and psychiatric comorbidity (53% and 40% vs 20%). On follow-up (mean 13-16 months), only 1 of the 191 patients with 'scan-negative' CES was diagnosed with an explanatory neurological disorder (transverse myelitis).&lt;h4>Conclusions&lt;/h4>The data support a model in which scan-negative cauda equina syndrome arises as an end pathway of acute pain, sometimes with partly structural findings and vulnerability to functional disorders.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Dec</publication><modification>2024-11-20T05:21:47.6Z</modification><creation>2019-03-27T00:10:16Z</creation></dates><accession>S-EPMC6244667</accession><cross_references><pubmed>30298195</pubmed><doi>10.1007/s00415-018-9078-2</doi></cross_references></HashMap>